Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies
- 31 July 2024
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (8) , 1-22
Abstract
Prostate cancer is one of the most common malignancies and a leading cause of death in men. Owing to its excellent anti-tumor effects, androgen deprivation therapy (ADT) is widely used in the treatment of prostate cancer. However, its use is controversial because of its potential for inducing cognitive decline. In this review, we summarized the findings of preclinical and clinical studies investigating the effects of ADT on cognitive function in prostate cancer. We discussed the methods used to assess cognitive function in these studies, elucidated the mechanisms through which ADT affects cognitive function, and highlighted recent advancements in cognitive assessment methods. The findings of this review serve as a valuable reference for examining the relationship between ADT and cognitive function in future studies. Besides, the findings may help clinicians understand the advantages and disadvantages of ADT and optimize the treatment plan so as to minimize the adverse effects of ADT.Keywords
Funding Information
- Shanghai Municipal Health Commission (No.202140348)
This publication has 84 references indexed in Scilit:
- Long-term exercise pre-training attenuates Alzheimer’s disease–related pathology in a transgenic rat model of Alzheimer’s diseaseGeroScience, 2022
- A 2‐year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancerCancer, 2021
- Hippocampal cellular changes in androgen deprived insulin resistant ratsMetabolic Brain Disease, 2021
- Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancerPsychopharmacology, 2019
- Effects of long‐term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancerCancer, 2016
- Amyloid-β and TauJAMA Neurology, 2014
- Combined androgen blockade with bicalutamide for advanced prostate cancerCancer, 2009
- Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non‐metastatic prostate cancerPsycho-Oncology, 2008
- Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly MenArchives of Neurology, 2006
- Glial expression of estrogen and androgen receptors after rat brain injuryJournal of Comparative Neurology, 2002